A CDMO specializing in novel pellet-based intermediates for generic drug formulations.
Annual revenue $855,750 Latest available
Total funding - Funding intelligence
Employees 33 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Apogen

Apogen is a company based in Hyderabad (India) by Bhanu Prasad Kommineni, Tamma Raghava Srinivasa Reddy, and Sastry Tvpc. It operates as a B2B. The company has 33 employees as of March 31, 2022. Apogen operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

  • Headquarter Hyderabad, India
  • Employees 33 as on 31 Mar, 2022
  • Founders Bhanu Prasad Kommineni, Tamma Raghava Srinivasa Reddy, Sastry Tvpc
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Apogen Remedies Private Limited
  • Date of Incorporation 05 Jul, 2011
  • Jurisdiction Siddipet, Telangana, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $855.75 K (USD)
    448.41
    as on Mar 31, 2022
  • Net Profit
    $236.98 K (USD)
    242.89
    as on Mar 31, 2022
  • EBITDA
    -$150.28 K (USD)
    -531.86
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    33

    as on Mar 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Apogen

Premium access

Detailed funding history for Apogen

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Apogen

Investments
Premium access

Investment portfolio details for Apogen

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Apogen

Premium access

Detailed financials for Apogen

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Apogen Comparisons

Apogen Primary company
Description
A CDMO specializing in novel pellet-based intermediates for ...
Location
Hyderabad, India
Founded Year
-
Annual Revenue
$855.75 K (USD)
Net Profit
$236.98 K (USD)
EBITDA
-$150.28 K (USD)
Employees
33
As of 2022
Premium access

Peer comparison for Apogen

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Apogen

Apogen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical and biotechnology company
Locked Locked Locked
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
Locked Locked Locked
APIs and drug products are developed and valorized in pharmaceuticals.
Locked Locked Locked
APIs, intermediates, and biochemical reagents are developed and manufactured.
Locked Locked Locked
APIs are developed and manufactured for therapeutic areas.
Locked Locked Locked
Contract development, manufacturing, and analytical services for APIs are offered.
Premium access

Detailed competitors of Apogen

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Apogen

Premium access

Complete news archive for Apogen

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Apogen

Apogen is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

As of Mar 31, 2022, the latest employee count at Apogen is 33.

Annual revenue of Apogen is $855.75K as on Mar 31, 2022.

Apogen a cdmo specializing in novel pellet-based intermediates for generic drug formulations through providing healthcare solutions, producing pharmaceutical products, drug development, and generic formulations. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Apogen's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available